Method and detection kit for detecting ERBB2 gene amplification based on digital PCR technology
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 杭州求臻医学检验实验室有限公司
- Publication Date
- 2021-03-26
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the technical field of molecular diagnosis, in particular to a method for detecting ERBB2 gene amplification based on digital PCR technology and a detection kit thereof. Background technique
[0002] The tyrosine kinase receptor ERBB2 (also known as ERBB2 / NEU) gene encodes a 185kDa transmembrane glycoprotein with tyrosine kinase activity and is a member of the EGFR family. Amplification or overexpression of the ERBB2 gene can lead to excessive proliferation of cells and the formation of tumors. Studies have shown that about 25% to 30% of invasive breast cancer and 80% of gastric cancer patients have ERBB2 gene amplification or protein overexpression.
[0003] ERBB2 amplification may be used to predict the body's sensitivity to ERBB2-targeted therapeutic drugs, such drugs include lapatinib, trastuzumab, pertuzumab, T-DM1, etc. Taking the earliest and most successful trastuzumab (Herceptin) as an example, clinical studies have ...